Data Show that Abbott's HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years Jun 13, 2008
PARIS, June 13 /PRNewswire-FirstCall/ -- Abbott announced new data from the open-label extension of the ATLAS (Adalimumab Trial Evaluating Long-Term Efficacy and Safety in AS) phase III clinical trial, which showed HUMIRA(R) (adalimumab) reduced the signs and symptoms of ankylosing spondylitis (AS) for up to three years of treatment among 74 percent of patients tested. AS is a type of arthritis that primarily causes inflammation of the spine and the spinal joints. (PR Newswire)
New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis Jun 13, 2008
PARIS, June 13 /PRNewswire-FirstCall/ -- Seven-year rheumatoid arthritis (RA) data from open-label extension studies show that treatment with Abbott's HUMIRA(R) (adalimumab) resulted in clinical remission among long-standing RA patients when used in combination with methotrexate (MTX). The percentage of patients achieving clinical remission continued to increase after two or more years of continuous treatment with combination therapy. (PR Newswire)
Do Marathoners Have More Skin Cancer Risk? Nov 21, 2006
Older PUVA Treatment Bests Newer NB-UVB in British Study. Nov. 20, 2006. (CBS News)
Psoriasis May Boost Risk Of Heart Attack Oct 12, 2006
Older PUVA Treatment Bests Newer NB-UVB in British Study. New Therapies May Control Incurable Skin Condition. (CBS News)
Some Skin Products Up Cancer Risk Aug 3, 2006
Older PUVA Treatment Bests Newer NB-UVB in British Study. Look Here For Web Sites, Info Featured On The Early Show In June. (CBS News)
Psoriasis Treatment: UVA Beats UVB Jul 19, 2006
Older PUVA Treatment Bests Newer NB-UVB in British Study ... But it takes about 16 to 19 PUVA treatments to put a psoriasis outbreak into remission ... On average, it took 17 PUVA treatments to clear psoriasis, vs. 28. (CBS News)
